Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page was updated to v3.5.3, replacing the prior v3.5.2, which reflects a new build of the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check49 days agoChange DetectedA new Revision: v3.5.0 label appears, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 in the footer. This is a metadata update and does not affect study details or user actions.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.4.2, and the previous Notice about lapse in government funding and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange DetectedA system notice about potential processing delays due to a lapse in government funding was added, the NIH Clinical Center is open, and the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.